GB0407175D0 - Ion channel - Google Patents
Ion channelInfo
- Publication number
- GB0407175D0 GB0407175D0 GBGB0407175.9A GB0407175A GB0407175D0 GB 0407175 D0 GB0407175 D0 GB 0407175D0 GB 0407175 A GB0407175 A GB 0407175A GB 0407175 D0 GB0407175 D0 GB 0407175D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- ion channel
- ion
- channel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 102000004310 Ion Channels Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0331—Animal model for proliferative diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0356—Animal model for processes and diseases of the central nervous system, e.g. stress, learning, schizophrenia, pain, epilepsy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Environmental Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Plant Pathology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0407175.9A GB0407175D0 (en) | 2004-03-30 | 2004-03-30 | Ion channel |
AU2005227712A AU2005227712A1 (en) | 2004-03-30 | 2005-03-30 | Ion channel |
CA002561534A CA2561534A1 (en) | 2004-03-30 | 2005-03-30 | Ion channel |
PCT/GB2005/001151 WO2005094569A1 (en) | 2004-03-30 | 2005-03-30 | Ion channel |
EP05731819A EP1729570A1 (en) | 2004-03-30 | 2005-03-30 | Ion channel |
JP2007505622A JP2007530069A (en) | 2004-03-30 | 2005-03-30 | Ion channel |
RU2006134657/13A RU2006134657A (en) | 2004-03-30 | 2005-03-30 | ION CHANNEL |
KR1020067017319A KR20060129411A (en) | 2004-03-30 | 2005-03-30 | Ion channel |
IL177601A IL177601A0 (en) | 2004-03-30 | 2006-08-21 | Ion channel |
US11/529,048 US20070101444A1 (en) | 2004-03-30 | 2006-09-28 | Ion channel |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0407175.9A GB0407175D0 (en) | 2004-03-30 | 2004-03-30 | Ion channel |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0407175D0 true GB0407175D0 (en) | 2004-05-05 |
Family
ID=32247524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0407175.9A Ceased GB0407175D0 (en) | 2004-03-30 | 2004-03-30 | Ion channel |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1729570A1 (en) |
JP (1) | JP2007530069A (en) |
AU (1) | AU2005227712A1 (en) |
CA (1) | CA2561534A1 (en) |
GB (1) | GB0407175D0 (en) |
RU (1) | RU2006134657A (en) |
WO (1) | WO2005094569A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101351473A (en) | 2005-10-31 | 2009-01-21 | 詹森药业有限公司 | A polypeptide complex of TRPM8 and calmodulin and its uses thereof |
US8629281B2 (en) | 2011-01-14 | 2014-01-14 | Janssen Pharmaceutica, Nv | Cold menthol receptor-1 antagonists |
EP2029614B1 (en) | 2006-05-10 | 2013-01-23 | Janssen Pharmaceutica, N.V. | Cold menthol receptor-1 antagonists |
GB0615136D0 (en) * | 2006-07-29 | 2006-09-06 | Univ Edinburgh | Induction of analgesia in neuropathic pain |
US8558011B2 (en) | 2010-08-31 | 2013-10-15 | Janssen Pharmaceutica, Nv | Cold menthol receptor-1 antagonists |
CN115974973A (en) * | 2021-10-14 | 2023-04-18 | 浙江大学 | Polypeptide for inhibiting TRPM8 and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194152B1 (en) * | 1997-08-20 | 2001-02-27 | Dendreon Corporation | Prostate tumor polynucleotide compositions and methods of detection thereof |
EP2006300A3 (en) * | 1998-12-30 | 2009-03-11 | Beth Israel Deaconess Medical Center, Inc. | Characterization of a calcium channel family |
AU2001265268A1 (en) * | 2000-06-01 | 2001-12-11 | Pharmacia And Upjohn Company | Mice heterozygous for wfs1 gene as mouse models for depression |
CA2450113A1 (en) * | 2001-06-13 | 2002-12-19 | Novartis Ag | Vanilloid receptor-related nucleic acids and polypeptides |
AU2003210663A1 (en) * | 2002-01-25 | 2003-09-02 | The Regents Of The University Of California | Methods of modulating cold sensory perception |
JP2006511197A (en) * | 2002-05-31 | 2006-04-06 | スローン − ケッタリング インスティチュート フォー キャンサー リサーチ | Heterogeneous stimulus-gated ion channel and method of use thereof |
-
2004
- 2004-03-30 GB GBGB0407175.9A patent/GB0407175D0/en not_active Ceased
-
2005
- 2005-03-30 EP EP05731819A patent/EP1729570A1/en not_active Withdrawn
- 2005-03-30 AU AU2005227712A patent/AU2005227712A1/en not_active Abandoned
- 2005-03-30 JP JP2007505622A patent/JP2007530069A/en active Pending
- 2005-03-30 CA CA002561534A patent/CA2561534A1/en not_active Abandoned
- 2005-03-30 WO PCT/GB2005/001151 patent/WO2005094569A1/en not_active Application Discontinuation
- 2005-03-30 RU RU2006134657/13A patent/RU2006134657A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2007530069A (en) | 2007-11-01 |
WO2005094569A8 (en) | 2006-10-19 |
RU2006134657A (en) | 2008-04-10 |
WO2005094569A1 (en) | 2005-10-13 |
AU2005227712A1 (en) | 2005-10-13 |
CA2561534A1 (en) | 2005-10-13 |
EP1729570A1 (en) | 2006-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1723123A4 (en) | Ion channel modulators | |
EP1723117A4 (en) | Ion channel modulators | |
EP1722783A4 (en) | Ion channel modulators | |
SG115784A1 (en) | Multiple channel earphone | |
IL181140A0 (en) | Ion mobility spectrometer | |
GB2412488B (en) | Ion sources | |
EP1722788A4 (en) | Ion channel modulators | |
EP1949676A4 (en) | Delay-less channel switching | |
ZA200701587B (en) | Ion mobility spectrometer | |
GB2413213B (en) | Ion selector | |
PL1600567T3 (en) | Drainage channel | |
GB0420396D0 (en) | Polyolefins | |
GB2409953B (en) | Clear channel assessment | |
EP1723120A4 (en) | Ion channel modulators | |
EP1722787A4 (en) | Ion channel modulators | |
EP1723119A4 (en) | Ion channel modulators | |
PL1863978T3 (en) | Channel body | |
EP1807987A4 (en) | Channel estimation | |
IL178212A0 (en) | Ion channel | |
IL177601A0 (en) | Ion channel | |
GB0407175D0 (en) | Ion channel | |
EP1722784A4 (en) | Ion channel modulators | |
GB2418774B (en) | Ion source combining esi-, fi-, fd- lifdi- and maldi elements | |
EP1725523A4 (en) | Ion channel modulators | |
EP1722785A4 (en) | Ion channel modulators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |